<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Obesity and asthma
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Obesity and asthma
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Obesity and asthma
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anne E Dixon, BM, BCh
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sharmilee Maria Nyenhuis, MD, FAAAAI
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Monica Kraft, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul Dieffenbach, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 15, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H126668764">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obesity is a risk factor for both incident and prevalent asthma. The interrelationship between obesity and asthma derives from a complex interplay of biologic, physiologic, and environmental factors. Asthma in patients who are obese is often severe and difficult to control [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         The epidemiology, potential contributing factors, clinical features, diagnosis, and management of coexistent asthma and obesity will be reviewed here. Overviews of obesity and asthma are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/5372.html" rel="external">
          "Obesity in adults: Prevalence, screening, and evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5371.html" rel="external">
          "Obesity in adults: Overview of management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5874.html" rel="external">
          "Definition, epidemiology, and etiology of obesity in children and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5869.html" rel="external">
          "Overview of the health consequences of obesity in children and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5742.html" rel="external">
          "Asthma in children younger than 12 years: Initial evaluation and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2624338257">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prevalence of asthma is increased in obesity, particularly in adult women [
         <a href="#rid1">
          1
         </a>
         ]. In the United States, asthma is significantly more prevalent in patients with obesity compared with the remainder of the population (14.6 versus 7.9 percent prevalence in females, 7.1 versus 6.1 percent prevalence in males)  (
         <a class="graphic graphic_figure graphicRef120911" href="/z/d/graphic/120911.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid2">
          2
         </a>
         ]. Over the past several decades, obesity and asthma have increased in parallel in the United States  (
         <a class="graphic graphic_figure graphicRef120909" href="/z/d/graphic/120909.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid3">
          3
         </a>
         ]. Among adults with severe asthma, nearly 60 percent are obese [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         An increased prevalence of asthma also occurs in children with obesity; the adjusted odds ratio of having asthma is 1.29 (95% CI 1.16-1.42) in obese compared with lean children [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         There is a dose-dependent effect of obesity on the risk of asthma, such that the greater the body mass index (BMI), the greater the risk of asthma. Compared with lean individuals, the risk of asthma is increased 1.4-fold for adults with a BMI of 30.0 to 34.9 kg/m
         <sup>
          2
         </sup>
         and 2.5-fold for adults with a BMI of 50 kg/m
         <sup>
          2
         </sup>
         and above [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         In some individuals, obesity precedes asthma, and obesity is a risk factor for the later development of asthma [
         <a href="#rid6">
          6,7
         </a>
         ]. In other individuals, asthma precedes obesity, suggesting that asthma or asthma treatment may be a risk factor for the development of obesity [
         <a href="#rid8">
          8,9
         </a>
         ]. Asthma at the age of three to four years is reported to increase the risk of obesity nearly twofold by age eight [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1009726044">
         <span class="h1">
          POTENTIAL CONTRIBUTING FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of factors related to obesity likely contribute to the increased risk and severity of asthma in obesity, but the exact pathogenesis is not known.
        </p>
        <p>
         The pathogenesis of asthma that develops in a patient with obesity may differ from asthma complicated by obesity; obesity and associated metabolic changes may cause the airway disease in the first scenario, while they may contribute to asthma severity in the latter.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic factors
         </strong>
         – Studies in monozygotic and dizygotic twins suggest that 8 percent of the genetic component of obesity is shared with asthma [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Environmental exposures
         </strong>
         – Observational studies suggest that exposure to air pollution and parental smoking are independent risk factors for the development of both obesity [
         <a href="#rid12">
          12-14
         </a>
         ] and asthma [
         <a href="#rid15">
          15,16
         </a>
         ] in children.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dietary factors
         </strong>
         – Poor dietary quality (eg, diets high in sugar or saturated fatty acids, or low in antioxidants or fiber) is associated with increased respiratory symptoms [
         <a href="#rid17">
          17
         </a>
         ] and contributes to the development of obesity. A meal high in saturated fatty acids can acutely increase airway inflammation [
         <a href="#rid18">
          18
         </a>
         ] and decrease lung function [
         <a href="#rid19">
          19
         </a>
         ]; conversely, a high-fiber supplement has the opposite effect [
         <a href="#rid20">
          20
         </a>
         ]. Low levels of micronutrients such as vitamin D may also contribute to the risk of asthma [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lung growth
         </strong>
         – Children with obesity have increased lung volume relative to airway caliber ("dysanapsis"), reflected by a lower than normal ratio of forced expiratory volume in one second to forced vital capacity (FEV
         <sub>
          1
         </sub>
         /FVC) despite normal values for FEV
         <sub>
          1
         </sub>
         and FVC [
         <a href="#rid21">
          21
         </a>
         ]. Dysanapsis thus contributes to airflow limitation in obesity. In addition, dysanapsis is associated with higher insulin levels, increased asthma exacerbations, and use of systemic glucocorticoids in children with asthma [
         <a href="#rid21">
          21,22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mechanical factors
         </strong>
         – Mass loading of the chest wall and abdomen with adipose tissue decreases the functional residual capacity (the lung volume at the end of normal tidal exhalation)  (
         <a class="graphic graphic_figure graphicRef120905" href="/z/d/graphic/120905.html" rel="external">
          figure 3
         </a>
         ); breathing at lower functional residual capacity may increase airway reactivity [
         <a href="#rid23">
          23
         </a>
         ]. However, patients with obesity breathe at similarly low lung volumes regardless of asthma status [
         <a href="#rid18">
          18
         </a>
         ], so other factors must also be involved.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adipose tissue mediators
         </strong>
         — Adipose tissue in individuals with obesity releases proinflammatory mediators, such as interleukin (IL)-6, tumor necrosis factor-alpha, and leptin, into the circulation, while release of anti-inflammatory adipokines, such as adiponectin, is decreased. High levels of circulating IL-6 produced by adipose tissue macrophages are associated with poor asthma control [
         <a href="#rid24">
          24
         </a>
         ], and markers of inflammation of adipose tissue are increased in patients with asthma and obesity compared with those with asthma alone [
         <a href="#rid25">
          25,26
         </a>
         ], implicating metabolic factors in the pathogenesis of asthma in obesity. Thus, the metabolic health of adipose tissue may be more important than the fat mass in terms of asthma severity [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immune cell function
         </strong>
         — Adaptive and innate immune cell function are altered in obesity. One such alteration is suppression of T-helper lymphocyte function involved in allergic responses [
         <a href="#rid25">
          25,27-30
         </a>
         ]. Innate lymphoid cells (ILCs), which respond to intrinsic damage signals rather than antigens, may contribute to asthma airway inflammation in obesity [
         <a href="#rid31">
          31
         </a>
         ]. Interactions between Th1 cells and airway smooth muscle cells may be enhanced in obese asthma [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Eosinophil function is also altered by obesity. While submucosal eosinophils are increased in obese patients with asthma relative to overweight and lean subjects, eosinophils in induced sputum and peripheral blood are not increased with obesity [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increased oxidative stress
         </strong>
         – Patients with obesity and late-onset (≥12 years) asthma have increased levels of oxidative stress, associated with impaired lung function [
         <a href="#rid34">
          34-36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Airway innervation
         </strong>
         – Animal models of obese asthma suggest high insulin levels in obesity increase airway innervation and reflex-mediated bronchoconstriction [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H417292136">
         <span class="h1">
          CLINICAL FEATURES
         </span>
        </p>
        <p class="headingAnchor" id="H2000772424">
         <span class="h2">
          Asthma symptoms and severity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Symptoms of asthma are the same in obese as in lean individuals and include wheeze, cough, shortness of breath, and nocturnal symptoms, although symptom severity may be greater with obesity. The clinical features and biomarkers that are altered in patients with obesity and asthma are summarized in the figure  (
         <a class="graphic graphic_figure graphicRef120907" href="/z/d/graphic/120907.html" rel="external">
          figure 4
         </a>
         ).
        </p>
        <p>
         Dyspnea is a common symptom in adults with obesity, but not all of them develop dyspnea. Few studies have elucidated the mechanisms of dyspnea in patients with obesity, but increased oxygen cost of breathing, higher rates of perceived exertion, and altered lung physiology likely contribute [
         <a href="#rid38">
          38-40
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increased severity and worse asthma control in obese adults
         </strong>
         – Adults with obesity tend to have worse asthma control (increased cough, wheeze, shortness of breath, and nocturnal symptoms) and a greater likelihood of requiring oral glucocorticoids than nonobese individuals [
         <a href="#rid41">
          41-43
         </a>
         ]. Adults with obesity have a two- to fourfold increased risk of being hospitalized for asthma exacerbations compared with lean patients [
         <a href="#rid41">
          41,44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increased severity in obese children
         </strong>
         – Children with asthma and obesity also have an increased risk of exacerbations, but the effect on asthma control is not as apparent. While some studies report that obese compared with lean children have worse asthma control [
         <a href="#rid45">
          45
         </a>
         ], a meta-analysis reported similar control in obese and lean children [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Symptoms of sinonasal disease that are common accompaniments of asthma do not appear to differ among obese and lean patients with asthma [
         <a href="#rid47">
          47
         </a>
         ]. Patients with asthma and obesity are more likely to report symptoms of gastroesophageal reflux and sleep disturbance than nonobese patients [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3622252150">
         <span class="h2">
          Asthma phenotypes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Among all patients with asthma, a varied spectrum of disease characteristics has been described and sometimes clusters of characteristics, such as age of onset, type of airway inflammation, and physiologic features, are reproducible enough to be considered phenotypes (see
         <a class="medical medical_review" href="/z/d/html/544.html" rel="external">
          "Severe asthma phenotypes"
         </a>
         ). Patients with obesity and asthma can be divided into two major categories: (1) asthma complicated by obesity and (2) asthma consequent to obesity; within each group additional phenotypes are still being described [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Asthma complicated by obesity
         </strong>
         – This phenotype likely includes all asthma phenotypes found in lean patients. The best-recognized phenotype is early-onset allergic asthma complicated by obesity. These patients have early-onset disease (typically &lt;12 years old), elevated markers of allergic inflammation (atopy, allergic symptoms, high serum immunoglobulin E), significant physiologic changes (airway obstruction and hyper-responsiveness), and severe disease [
         <a href="#rid41">
          41
         </a>
         ]. These patients gain weight faster than those with later-onset disease [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Asthma consequent to obesity
         </strong>
         – Many patients with asthma and obesity have later-onset disease (≥12 years old), less allergic inflammation, and are more likely to be female [
         <a href="#rid41">
          41
         </a>
         ]. Their asthma is typically characterized by less airflow obstruction and hyper-responsiveness and is less severe than patients with the earlier-onset disease. There are likely many phenotypes within this population; some patients appear to have neutrophilic airway inflammation, whereas others have little in the way of overt cellular airway inflammation [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3519175484">
         <span class="h2">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Apart from obesity, the physical examination may be normal during periods of asthma quiescence, with tachypnea, wheezing, and prolonged expiration appearing during exacerbations. Stigmata of atopy (eg, allergic rhinitis, atopic dermatitis) may be present, particularly in patients with childhood onset of asthma. (See
         <a class="medical medical_review" href="/z/d/html/83038.html" rel="external">
          "The relationship between IgE and allergic disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3720227918">
         <span class="h1">
          EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The evaluation of asthma in patients with obesity is largely the same as in other patients with asthma and is based on a compatible history and demonstration of variable expiratory airflow limitation (preferably by spirometry). Additional testing may be needed to rule out conditions that might mimic asthma. (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1339118391">
         <span class="h2">
          History
         </span>
         <span class="headingEndMark">
          —
         </span>
         A detailed history that characterizes the pattern (episodic, continuous), triggers (work, exercise, aeroallergen exposure, smoke exposure) of symptoms, and timing of onset of obesity and asthma is a key part of the evaluation of asthma in all patients  (
         <a class="graphic graphic_table graphicRef80507" href="/z/d/graphic/80507.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_figure graphicRef120908" href="/z/d/graphic/120908.html" rel="external">
          figure 5
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/562.html" rel="external">
          "Trigger control to enhance asthma management"
         </a>
         .)
        </p>
        <p>
         Additionally, concomitant symptoms should be explored, particularly those suggestive of comorbid conditions such as rhinosinusitis, obstructive sleep apnea, gastroesophageal reflux disease, metabolic syndrome, and depression, which are more common in obesity and may complicate the disease. (See
         <a class="local">
          'Evaluation of comorbidities'
         </a>
         below.)
        </p>
        <p>
         Identifying the age of onset of asthma and the age of onset of obesity may help distinguish between different phenotypes of obese asthma, which may have implications for disease treatment. (See
         <a class="local">
          'Asthma phenotypes'
         </a>
         above.)
        </p>
        <p>
         Identifying triggers for asthma can help distinguish asthma phenotype (allergic versus nonallergic) and identify environmental factors that could be contributing to worsening disease (exposure to tobacco smoke or environmental pollution)  (
         <a class="graphic graphic_table graphicRef80507" href="/z/d/graphic/80507.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/562.html" rel="external">
          "Trigger control to enhance asthma management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1380279629">
         <span class="h2">
          Determination of obesity
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, the determination of obesity is based on the body mass index (BMI). In adults, a BMI ≥30 kg/m
         <sup>
          2
         </sup>
         is considered obese; in children, a BMI ≥95
         <sup>
          th
         </sup>
         percentile for age and sex is considered obese  (
         <a class="graphic graphic_table graphicRef134390" href="/z/d/graphic/134390.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5372.html" rel="external">
          "Obesity in adults: Prevalence, screening, and evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5874.html" rel="external">
          "Definition, epidemiology, and etiology of obesity in children and adolescents"
         </a>
         .)
        </p>
        <p>
         While BMI is commonly used to assess obesity, the actual distribution of fat can influence the effects of adipose tissue on pulmonary and cardiometabolic effects (eg, increased preperitoneal fat mass, but not BMI, is associated with higher fraction of exhaled nitric oxide [FE
         <sub>
          NO
         </sub>
         ]), raising the possibility that other measures of fat distribution (eg, waist circumference) might provide a better correlation with clinical effects [
         <a href="#rid50">
          50,51
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4010925400">
         <span class="h2">
          Pulmonary function testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obesity, unless severe or combined with another respiratory disease, has minimal effect on spirometric values and gas transfer. When severe, chest wall and abdominal obesity can cause reduced chest wall and lung compliance with associated restrictive changes in lung volumes and increased work of breathing. These changes are described separately. (See
         <a class="medical medical_review" href="/z/d/html/4320.html" rel="external">
          "Chest wall diseases and restrictive physiology", section on 'Obesity'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H96295787">
         <span class="h3">
          Spirometry with bronchodilator reversibility
         </span>
         <span class="headingEndMark">
          —
         </span>
         Assessment of reversible airflow limitation by spirometry with inhaled bronchodilator reversibility testing is a cornerstone of asthma diagnosis. If airflow obstruction is present, a diagnosis of asthma requires bronchodilator testing to determine reversibility, while absence of airflow limitation requires bronchoprovocation testing or evidence of reversible airflow limitation over time. (See
         <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">
          "Overview of pulmonary function testing in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/569.html" rel="external">
          "Pulmonary function testing in asthma"
         </a>
         .)
        </p>
        <p>
         Adults with asthma and obesity often have normal baseline pulmonary function tests without airflow limitation (defined as a ratio of forced expiratory volume in one second to forced vital capacity [FEV
         <sub>
          1
         </sub>
         /FVC] &lt;0.7 or less than the lower limit of normal), or may have a slight decrease in FEV
         <sub>
          1
         </sub>
         and FVC without a decrease in the ratio [
         <a href="#rid48">
          48
         </a>
         ]. In one study in adults, for every one unit increase in BMI, FEV
         <sub>
          1
         </sub>
         decreased by 0.47 (95% CI -0.76 to -0.17) percent, and FVC decreased by 0.40 (95% CI -0.66 to -0.14) percent, when corrected for age, sex, and clinic site [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
         In contrast, children with asthma and obesity are more likely to have “dysanapsis” with increased FVC, but reduced flow (FEV
         <sub>
          1
         </sub>
         and FEV
         <sub>
          1
         </sub>
         /FVC) [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="local">
          'Potential contributing factors'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H2749752883">
         <span class="h3">
          Bronchoprovocation testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchoprovocation testing with pharmacologic agents (eg,
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         ) or physical challenge with eucapnic voluntary ventilation or exercise is useful when patients have symptoms suggestive of asthma, but do not have airflow limitation on spirometry. The techniques for bronchoprovocation testing are described separately. (See
         <a class="medical medical_review" href="/z/d/html/525.html" rel="external">
          "Bronchoprovocation testing"
         </a>
         .)
        </p>
        <p>
         Asthma in individuals with obesity is associated with increased airway hyperresponsiveness (AHR; positive bronchoprovocation challenge) whether asthma is early onset (&lt;12 years of age)-allergic or late onset-nonallergic [
         <a href="#rid52">
          52
         </a>
         ]. However, weight loss is associated with decreased AHR in the late onset-nonallergic group, but not the early onset-allergic group. At least a component of the increased AHR in the late onset-nonallergic group appears related to collapsibility of the airways (increased airway elasticity) that leads to airway closure at a reduced functional residual capacity (FRC) associated with obesity.
        </p>
        <p class="headingAnchor" id="H2591648431">
         <span class="h3">
          Fraction of exhaled nitric oxide
         </span>
         <span class="headingEndMark">
          —
         </span>
         FE
         <sub>
          NO
         </sub>
         levels tend to be slightly lower in adults with asthma and obesity compared with lean or overweight adults [
         <a href="#rid53">
          53,54
         </a>
         ]. Children with asthma and a low FE
         <sub>
          NO
         </sub>
         are more likely to have increased adiposity indicators (BMI, percent body fat, and waist circumference), while children with asthma and a high FE
         <sub>
          NO
         </sub>
         are likely to have poorly controlled asthma [
         <a href="#rid55">
          55
         </a>
         ]. A FE
         <sub>
          NO
         </sub>
         level of 14.5 parts per billion (ppb) has been suggested as a threshold for identifying eosinophilic disease in patients with obesity, which is substantially lower than the usual cut-point of 25 ppb in adults [
         <a href="#rid53">
          53
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/542.html" rel="external">
          "Exhaled nitric oxide analysis and applications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1279217759">
         <span class="h2">
          Laboratory testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with uncontrolled moderate to severe persistent asthma, we obtain a complete blood count with differential to assess for anemia and eosinophilia, a total serum immunoglobulin E (IgE) level, and allergy testing to environmental allergens (allergy skin tests or immunoassays for allergen-specific serum IgE). In patients with severe asthma, we obtain an alpha-1 antitrypsin level. (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Evaluation'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Thresholds for eosinophilia
         </strong>
         – Obesity appears to decrease biomarkers of eosinophilic inflammation, but specific thresholds to identify eosinophilic disease in patients with obesity are not well-defined. In a series of 652 patients with asthma, those with obesity were less likely to have evidence of eosinophilic inflammation defined as a sputum eosinophil count &gt;2 percent, blood eosinophil count &gt;300 cells/microL, or FE
         <sub>
          NO
         </sub>
         &gt;25 ppb [
         <a href="#rid53">
          53
         </a>
         ]. While serum IgE and peripheral blood eosinophil levels have a good correlation among patients with obesity [
         <a href="#rid53">
          53
         </a>
         ], peripheral blood and induced sputum eosinophils are likely to underestimate the severity of airway eosinophilia [
         <a href="#rid33">
          33
         </a>
         ]. (See
         <a class="local">
          'Patients with severe asthma'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2841652440">
         <span class="h2">
          Evaluation of comorbidities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with asthma and obesity often have multiple comorbidities such as sleep-disordered breathing, gastroesophageal reflux, metabolic syndrome, and depression [
         <a href="#rid56">
          56
         </a>
         ]. These comorbidities may affect asthma control. To evaluate for comorbid conditions that might mimic or contribute to worsening asthma especially in patients with obesity, we consider the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Obstructive sleep apnea (OSA)
         </strong>
         – Several epidemiologic studies support a strong relationship between OSA and obesity, and OSA is associated with worse asthma control, increased health care utilization, and neutrophilic airway inflammation [
         <a href="#rid57">
          57,58
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">
          "Clinical presentation and diagnosis of obstructive sleep apnea in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Severe or untreated OSA can worsen asthma, reduce functional capacity, and lead to pulmonary hypertension [
         <a href="#rid59">
          59-61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         As part of the history, patients should be asked about snoring, sleep quality, nocturnal wakening, and daytime sleepiness; formal documentation using the Epworth Sleepiness Scale may be helpful (
         <a class="calc calc_professional" href="/z/d/html/13440.html" rel="external">
          calculator 1
         </a>
         ). Additional studies, such as home sleep apnea testing or in-laboratory polysomnography, may be indicated to evaluate for OSA. (See
         <a class="medical medical_review" href="/z/d/html/6363.html" rel="external">
          "Evaluation of suspected obstructive sleep apnea in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">
          "Clinical presentation and diagnosis of obstructive sleep apnea in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7688.html" rel="external">
          "Quantifying sleepiness", section on 'Epworth Sleepiness Scale (ESS)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gastroesophageal reflux disease
         </strong>
         – Gastroesophageal reflux disease (GERD) is increased in obese adults and children with asthma [
         <a href="#rid62">
          62,63
         </a>
         ]. While the relationship of GERD to asthma is not entirely clear [
         <a href="#rid57">
          57,63
         </a>
         ], GERD may trigger asthma symptoms in some patients. Symptoms of heartburn, regurgitation, sour taste, and chest pain are typical. This topic is discussed in more detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2265.html" rel="external">
          "Clinical manifestations and diagnosis of gastroesophageal reflux in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5892.html" rel="external">
          "Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/571.html" rel="external">
          "Gastroesophageal reflux and asthma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Metabolic Syndrome
         </strong>
         – Metabolic syndrome, characterized by abdominal obesity, insulin resistance, hypertriglyceridemia, and hypertension, is more common in obesity, affecting approximately 60 percent of those who are obese, and may contribute to asthma pathogenesis [
         <a href="#rid35">
          35,64,65
         </a>
         ]. Serum interleukin (IL)-6, a marker of the metabolic syndrome, is increased in patients with poor asthma control [
         <a href="#rid24">
          24
         </a>
         ]. Patients with severe asthma and insulin resistance also show blunted responses to inhaled short-acting beta-agonists and systemic glucocorticoids, as well as greater decline in lung function over time [
         <a href="#rid66">
          66
         </a>
         ]. If not already obtained, glycated hemoglobin A1C may be appropriate to identify diabetes. (See
         <a class="medical medical_review" href="/z/d/html/1784.html" rel="external">
          "Metabolic syndrome (insulin resistance syndrome or syndrome X)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Depression
         </strong>
         – The incidence of depression is increased in obese patients with asthma and has been associated with poor asthma control [
         <a href="#rid67">
          67,68
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Additional asthma comorbidities not specifically related to obesity are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/564.html" rel="external">
          "Evaluation of severe asthma in adolescents and adults", section on 'Assessing comorbid conditions'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1806735795">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of asthma is the same in obese and nonobese individuals and is based on a compatible history of respiratory symptoms (eg, wheeze, shortness of breath, chest tightness, and cough) that vary over time and in intensity, demonstration of variable expiratory airflow limitation (preferably by spirometry), and exclusion of an alternative diagnosis. The key point in patients with obesity is that exclusion of alternative diagnoses becomes more important. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
         Concerns about overdiagnosis of asthma have been raised as obese patients are more likely to have dyspnea symptoms, although in at least one study overdiagnosis was no greater in obese than nonobese patients [
         <a href="#rid69">
          69
         </a>
         ]. Nonetheless, diagnostic precision is essential to optimal management.
        </p>
        <p class="headingAnchor" id="H191895142">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of asthma in individuals with obesity is similar to other patients. (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Differential diagnosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5742.html" rel="external">
          "Asthma in children younger than 12 years: Initial evaluation and diagnosis", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
         When evaluating patients with obesity for possible asthma, particular attention should be directed to excluding disease processes that are more common in obesity and mimic asthma symptoms (wheezing, dyspnea, cough, and nocturnal symptoms) including the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Goiter with hypothyroidism
         </strong>
         – Patients with obesity due to hypothyroidism can have cervical or intrathoracic goiter causing tracheal compression  (
         <a class="graphic graphic_diagnosticimage graphicRef70903" href="/z/d/graphic/70903.html" rel="external">
          image 1
         </a>
         ). Patients with tracheal compression typically complain of dyspnea on exertion. Physical examination can identify extrathoracic goiter, but chest imaging is needed to identify intrathoracic goiter. (See
         <a class="medical medical_review" href="/z/d/html/7835.html" rel="external">
          "Clinical presentation and evaluation of goiter in adults", section on 'Obstructive symptoms'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chest wall compression
         </strong>
         – Class 3 or higher obesity  (
         <a class="graphic graphic_table graphicRef134390" href="/z/d/graphic/134390.html" rel="external">
          table 2
         </a>
         ) in the absence of asthma can cause exertional and nocturnal dyspnea. Chest wall adipose tissue can compress the chest cavity, intra-abdominal adipose tissue can impede diaphragmatic motion, and intrathoracic adipose tissue can (rarely) cause tracheal compression and dyspnea [
         <a href="#rid70">
          70,71
         </a>
         ]. Symptoms may be exacerbated by recumbency. Pulmonary function tests typically show irreversible airflow limitation, but restrictive or mixed defects can also be seen. Imaging is needed for a diagnosis of tracheal compression. (See
         <a class="medical medical_review" href="/z/d/html/4320.html" rel="external">
          "Chest wall diseases and restrictive physiology", section on 'Obesity'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Heart failure with preserved ejection fraction (HFpEF)
         </strong>
         – Obesity is a leading risk factor for HFpEF, and symptoms associated with HFpEF include dyspnea on exertion, paroxysmal nocturnal dyspnea, and orthopnea, which overlap with asthma. It is important to note that natriuretic peptide levels can be normal in patients with obesity and HFpEF, and echocardiography is needed to make the diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/3504.html" rel="external">
          "Heart failure with preserved ejection fraction: Clinical manifestations and diagnosis", section on 'Evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiovascular deconditioning
         </strong>
         – Cardiovascular deconditioning can accompany obesity and be a cause of exertional dyspnea. Cardiopulmonary exercise testing (CPET) can help to assess functional capacity and the physiologic performance of the cardiovascular and respiratory systems in unison. (See
         <a class="medical medical_review" href="/z/d/html/1436.html" rel="external">
          "Approach to the patient with dyspnea"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary hypertension
         </strong>
         – Among patients with obesity, pulmonary hypertension can develop as a consequence of nocturnal hypoxemia and HFpEF. In addition, the use of some appetite suppressants (generally no longer in use) is associated with pulmonary hypertension. Transthoracic echocardiogram is needed for diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/8247.html" rel="external">
          "The epidemiology and pathogenesis of pulmonary arterial hypertension (Group 1)", section on 'Drugs and toxins'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8249.html" rel="external">
          "Clinical features and diagnosis of pulmonary hypertension of unclear etiology in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2628643171">
         <span class="h1">
          MANAGEMENT OF ASTHMA IN THE OBESE PATIENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The management of asthma is largely similar regardless of obesity. Potential differences in patients with obesity include reduced responsiveness to standard controller medications, thresholds for determination of asthma phenotype to guide biologic therapy, importance of comorbidities, and the role of weight reduction. These differences are outlined in the following sections.
        </p>
        <p class="headingAnchor" id="H3392444397">
         <span class="h2">
          Pharmacologic therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pharmacologic treatment is the mainstay of treatment in most patients with asthma; however, treatment of comorbidities and lifestyle interventions are particularly important in patients who also suffer from obesity. Asthma medication guidelines do not differ, although patients with obesity may not be as responsive to standard therapies. (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management"
         </a>
         .)
        </p>
        <p>
         All patients with asthma should have quick relief rescue therapy (see
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management"
         </a>
         ) to be used as needed for asthma symptoms and be instructed in the correct inhaler technique. However, a portion of obese Black or Hispanic adolescents may be less responsive to inhaled beta-agonists than their nonobese peers [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1464304758">
         <span class="h3">
          Patients who need daily controller medication
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with persistent asthma (the majority of patients with obesity and asthma) should be treated with controller medication according to international guidelines. Inhaled glucocorticoids (also called inhaled corticosteroids [ICS]) reduce the frequency of asthma symptoms, improve asthma-related quality of life, and reduce the risk of severe asthma exacerbations [
         <a href="#rid56">
          56,73
         </a>
         ]. However, studies show attenuated responses to inhaled glucocorticoids in obese patients over the age of five years [
         <a href="#rid74">
          74-76
         </a>
         ], but not among preschool children [
         <a href="#rid77">
          77
         </a>
         ]. Combination therapy with inhaled glucocorticoids and a long-acting beta agonist is more likely to result in asthma control than inhaled glucocorticoids alone, but is less effective in achieving asthma control in patients with obesity compared with other patients [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
         Additional therapies such as long-acting muscarinic antagonists and leukotriene-modifying agents can be added to ICS if asthma is not well-controlled or the patient's asthma is more severe. In a randomized trial of
         <a class="drug drug_general" data-topicid="10300" href="/z/d/drug information/10300.html" rel="external">
          tiotropium
         </a>
         step-up therapy in 210 patients with asthma, tiotropium resulted in improved symptoms and lung function [
         <a href="#rid78">
          78
         </a>
         ]. While obesity was not specifically studied, the mean body-mass index of study subjects was 31.4, suggesting that antimuscarinic agents are effective in patients with asthma and obesity.
        </p>
        <p>
         Limited data suggest that leukotriene-modifying agents help to maintain asthma control in the obese population [
         <a href="#rid74">
          74,79
         </a>
         ], although a retrospective analysis of four clinical trials found that combination
         <a class="drug drug_general" data-topicid="8730" href="/z/d/drug information/8730.html" rel="external">
          fluticasone-salmeterol
         </a>
         was more effective than
         <a class="drug drug_general" data-topicid="9539" href="/z/d/drug information/9539.html" rel="external">
          montelukast
         </a>
         even at a high body mass index [
         <a href="#rid80">
          80
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10281" href="/z/d/drug information/10281.html" rel="external">
          Theophylline
         </a>
         is associated with increased asthma exacerbations among obese patients compared with nonobese patients and is rarely used in this setting [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="16465" href="/z/d/drug information/16465.html" rel="external">
          Roflumilast
         </a>
         is also associated with an increased risk of asthma exacerbation in individuals with obesity and poorly controlled asthma [
         <a href="#rid81">
          81
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H81108390">
         <span class="h3">
          Patients with severe asthma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many patients with obesity and asthma meet criteria for severe asthma. In these patients, we redouble efforts to optimize daily controller medications, asthma education, trigger avoidance, and treatment of comorbidities. We avoid long-term treatment with systemic glucocorticoids if at all possible because the side effects of weight gain and metabolic dysfunction are likely to worsen disease in this patient population in the long-term. As an alternative, we evaluate these patients for treatment with biologic agents. (See
         <a class="local">
          'Treatment of comorbidities'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/551.html" rel="external">
          "Treatment of severe asthma in adolescents and adults", section on 'Persistently uncontrolled asthma'
         </a>
         .)
        </p>
        <p>
         When selecting a biologic agent, we consider the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         While some studies have reported that patients with obesity have a less favorable response to anti-IgE therapy, the balance of evidence suggests similar effectiveness regardless of body mass [
         <a href="#rid82">
          82-85
         </a>
         ]; however, weight-based dosing precludes
         <a class="drug drug_general" data-topicid="10251" href="/z/d/drug information/10251.html" rel="external">
          omalizumab
         </a>
         therapy in patients with a body weight above 150 kg. (See
         <a class="medical medical_review" href="/z/d/html/545.html" rel="external">
          "Anti-IgE therapy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The antiinterleukin-5 medication
         <a class="drug drug_general" data-topicid="105352" href="/z/d/drug information/105352.html" rel="external">
          mepolizumab
         </a>
         reduces asthma exacerbations similarly in both lean and obese patients but has reduced efficacy in improving lung function in people with obesity [
         <a href="#rid86">
          86
         </a>
         ].
         <a class="drug drug_general" data-topicid="115768" href="/z/d/drug information/115768.html" rel="external">
          Benralizumab
         </a>
         , another antiinterleukin-5 medication, may have slightly less efficacy at reducing exacerbations in those with BMI &gt;35 kg/m
         <sup>
          2
         </sup>
         [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Traditional thresholds for eosinophilic disease may not be appropriate in patients with asthma and obesity (see
         <a class="local">
          'Laboratory testing'
         </a>
         above) [
         <a href="#rid53">
          53
         </a>
         ]. A blood eosinophil count of 96 cells/microL has been suggested as a cutpoint for identifying eosinophilic inflammation in these patients [
         <a href="#rid53">
          53
         </a>
         ], but further research is needed to determine the optimal cutpoints for responsiveness to antieosinophilic biologic agents.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3515475525">
         <span class="h2">
          Treatment of comorbidities
         </span>
         <span class="headingEndMark">
          —
         </span>
         While large studies evaluating whether treatment of comorbidities improves asthma control in patients with obesity are lacking, conditions such as obstructive sleep apnea, gastroesophageal reflux, metabolic syndrome, and depression warrant treatment in their own right as serious comorbidities [
         <a href="#rid56">
          56,73
         </a>
         ]. Treatment of these comorbid conditions is discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obstructive sleep apnea (see
         <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">
          "Obstructive sleep apnea: Overview of management in adults"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastroesophageal reflux disease (see
         <a class="medical medical_review" href="/z/d/html/571.html" rel="external">
          "Gastroesophageal reflux and asthma"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic syndrome (see
         <a class="medical medical_review" href="/z/d/html/1784.html" rel="external">
          "Metabolic syndrome (insulin resistance syndrome or syndrome X)", section on 'Therapy'
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Depression (see
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1231.html" rel="external">
          "Overview of prevention and treatment for pediatric depression"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1150635192">
         <span class="h2">
          Weight loss interventions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Weight loss interventions range from liquid-diet replacement to diet and exercise to bariatric surgery [
         <a href="#rid53">
          53,88-90
         </a>
         ]. In general, studies of weight loss interventions show improvements in asthma control, asthma-related quality of life, and lung function if a sufficient amount of weight loss (at least 5 percent) is attained [
         <a href="#rid88">
          88,90-92
         </a>
         ]. An approach to weight loss interventions is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5371.html" rel="external">
          "Obesity in adults: Overview of management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Behavioral lifestyle interventions
         </strong>
         – Behavioral lifestyle interventions have been successful in achieving and maintaining weight loss in hypertension and diabetes. In asthma, evidence of benefit is accruing with behavioral lifestyle interventions that incorporate diet and exercise with studies showing improvements in spirometry, asthma control, quality of life, airway inflammation, and exacerbation frequency depending on the outcomes examined [
         <a href="#rid1">
          1,93-95
         </a>
         ]. In a systematic review, four randomized trials involving children (n = 246) and adults (n = 502) used various combinations dietary restrictions, exercise, and cognitive behavioral therapy (CBT) and found improvements in asthma-related quality of life and, to some degree, asthma control [
         <a href="#rid93">
          93
         </a>
         ]. Differences in interventions, outcomes, and duration precluded pooled analysis. Effects on airway reactivity are variable [
         <a href="#rid96">
          96,97
         </a>
         ], perhaps due to heterogeneity among patients with asthma and obesity in the studies. (See
         <a class="medical medical_review" href="/z/d/html/5382.html" rel="external">
          "Obesity in adults: Behavioral therapy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Drug therapy for obesity
         </strong>
         – Drug therapy for obesity (eg,
         <a class="drug drug_general" data-topicid="10179" href="/z/d/drug information/10179.html" rel="external">
          orlistat
         </a>
         ,
         <a class="drug drug_general" data-topicid="9522" href="/z/d/drug information/9522.html" rel="external">
          liraglutide
         </a>
         , and others) may be appropriate for some patients who have not lost weight with behavioral lifestyle interventions alone, but these agents have not been specifically studied in patients with asthma. Individualized discussion of the risks and benefits is advisable. (See
         <a class="medical medical_review" href="/z/d/html/5376.html" rel="external">
          "Obesity in adults: Drug therapy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bariatric surgery
         </strong>
         – For patients with asthma and obesity, bariatric surgery is typically reserved for those with a BMI ≥35 kg/m
         <sup>
          2
         </sup>
         who have not been able to lose sufficient
         <sup>
         </sup>
         weight by other methods. As bariatric surgery carries the risk of peri- and postoperative morbidity that may be exacerbated by severe asthma and requires lifelong lifestyle changes, a careful evaluation of the risks and benefits of surgery should be discussed in detail with each patient. (See
         <a class="medical medical_review" href="/z/d/html/586.html" rel="external">
          "Bariatric surgery for management of obesity: Indications and preoperative preparation", section on 'Indications'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/87686.html" rel="external">
          "Bariatric operations: Early (fewer than 30 days) morbidity and mortality"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94358.html" rel="external">
          "Anesthesia for adult patients with asthma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Bariatric surgery can produce significant weight loss, and nonrandomized prospective and retrospective data suggest that it can improve asthma control, airway reactivity, and lung function [
         <a href="#rid25">
          25,98-103
         </a>
         ]. Additionally, a self-controlled case series of 2261 patients suggests that bariatric surgery can reduce asthma exacerbations by almost 60 percent [
         <a href="#rid103">
          103,104
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1900481407">
         <span class="h2">
          Vaccinations
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with obesity are at increased risk of severe disease from influenza, so annual administration of influenza vaccine is recommended [
         <a href="#rid105">
          105-107
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7007.html" rel="external">
          "Seasonal influenza vaccination in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5960.html" rel="external">
          "Seasonal influenza in children: Prevention with vaccines"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with asthma are at increased risk from pneumococcal disease [
         <a href="#rid108">
          108
         </a>
         ]; pneumococcal vaccination is recommended for obese patients with asthma as described elsewhere  (
         <a class="graphic graphic_table graphicRef143140" href="/z/d/graphic/143140.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_table graphicRef143139" href="/z/d/graphic/143139.html" rel="external">
          table 4
         </a>
         and
         <a class="graphic graphic_algorithm graphicRef119302" href="/z/d/graphic/119302.html" rel="external">
          algorithm 1
         </a>
         and
         <a class="graphic graphic_algorithm graphicRef119305" href="/z/d/graphic/119305.html" rel="external">
          algorithm 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/7021.html" rel="external">
          "Pneumococcal vaccination in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6053.html" rel="external">
          "Pneumococcal vaccination in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2163816845">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113453.html" rel="external">
          "Society guideline links: Asthma in children"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/112325.html" rel="external">
          "Society guideline links: Asthma in adolescents and adults"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/112676.html" rel="external">
          "Society guideline links: Severe asthma in adolescents and adults"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/111346.html" rel="external">
          "Society guideline links: Obesity in children"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/111344.html" rel="external">
          "Society guideline links: Obesity in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2039627638">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (See
         <a class="medical medical_basics" href="/z/d/html/15343.html" rel="external">
          "Patient education: Asthma in adults (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/15344.html" rel="external">
          "Patient education: Asthma in children (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16111.html" rel="external">
          "Patient education: Avoiding asthma triggers (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/83815.html" rel="external">
          "Patient education: Health risks of obesity (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/15486.html" rel="external">
          "Patient education: Weight loss treatments (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16192.html" rel="external">
          "Patient education: Shortness of breath (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16896.html" rel="external">
          "Patient education: Cough in adults (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16897.html" rel="external">
          "Patient education: Cough in children (The Basics)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (See
         <a class="medical medical_patient" href="/z/d/html/1222.html" rel="external">
          "Patient education: Asthma symptoms and diagnosis in children (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/373.html" rel="external">
          "Patient education: Trigger avoidance in asthma (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/371.html" rel="external">
          "Patient education: Asthma treatment in adolescents and adults (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/4644.html" rel="external">
          "Patient education: Chronic cough in adults (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/4648.html" rel="external">
          "Patient education: Shortness of breath (dyspnea) (Beyond the Basics)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2106224623">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Obesity is a risk factor for the development of asthma, and asthma may increase the risk of developing obesity. Adults and children with obesity have a greater risk of exacerbations than lean adults and children. In adults, but not children, obesity is associated with worse asthma control. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Asthma symptoms and severity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Symptoms of asthma are the same in all individuals and include wheeze, cough, shortness of breath, and nocturnal symptoms, although symptom severity, particularly dyspnea, may be greater with obesity. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation and diagnosis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The evaluation and diagnosis of asthma in patients with obesity is largely the same as in other patients and is based on a compatible history and demonstration of variable expiratory airflow limitation (preferably by spirometry), with additional testing to rule out conditions that might mimic asthma. (See
         <a class="local">
          'Evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Peripheral blood and induced sputum eosinophils are likely to underestimate the severity of airway eosinophilia in obese patients. (See
         <a class="local">
          'Laboratory testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pharmacologic management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Initial pharmacologic therapy for asthma in patients with obesity follows standard guidelines. While some of these patients have reduced response to inhaled glucocorticoids or combination therapy with inhaled glucocorticoid-long-acting beta agonists, these medications generally perform better than leukotriene receptor antagonists, and combination therapy performs better than inhaled glucocorticoid alone. Long-acting muscarinic antagonists added to inhaled glucocorticoids are as effective in all patients with asthma. (See
         <a class="local">
          'Pharmacologic therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When selecting a biologic agent for patients with severe asthma and obesity, weight-based dosing of anti-IgE agents precludes therapy in patients with a body weight above 150 kg. Obesity appears to decrease biomarkers of eosinophilic inflammation, but specific trials using different eosinophil cut-points for the use of anti-eosinophil agents in obese patients are lacking. (See
         <a class="local">
          'Patients with severe asthma'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A brief course of an oral glucocorticoids may be needed periodically to treat an asthma exacerbation, but every effort should be made to avoid long-term use of oral glucocorticoids in this population. (See
         <a class="local">
          'Pharmacologic therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Comorbidities
         </strong>
         – Comorbidities such as obstructive sleep apnea, gastroesophageal reflux disease, metabolic syndrome, and depression, are more common in patients with obesity and are associated with poor asthma control. Screening for and treating these conditions is prudent, especially in patients with poorly controlled asthma. (See
         <a class="local">
          'Evaluation of comorbidities'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Effect of weight loss on asthma
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Behavioral lifestyle interventions that incorporate diet and exercise and achieve weight loss of at least 5 to 10 percent may improve asthma control and quality of life, although data are limited. (See
         <a class="local">
          'Weight loss interventions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bariatric surgery is typically reserved for patients with a BMI ≥35 kg/m
         <sup>
          2
         </sup>
         and an associated comorbidity, such as severe asthma. It can lead to significant improvements in asthma control and reduce the risk of asthma exacerbations. As severe asthma increases the risk of adverse outcomes from major surgery, a careful evaluation of the risks and benefits of surgery should be discussed in detail with each patient.
         <sup>
         </sup>
         (See
         <a class="local">
          'Weight loss interventions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preventative health maintenance
         </strong>
         – Patients with asthma and obesity should be vaccinated against influenza annually and pneumococcus according to the following schedules  (
         <a class="graphic graphic_table graphicRef86782" href="/z/d/graphic/86782.html" rel="external">
          table 5
         </a>
         ). (See
         <a class="local">
          'Vaccinations'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Peters U, Dixon AE, Forno E. Obesity and asthma. J Allergy Clin Immunol 2018; 141:1169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akinbami LJ, Fryar CD. Current Asthma Prevalence by Weight Status Among Adults: United States, 2001-2014. NCHS Data Brief 2016; :1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sin DD, Sutherland ER. Obesity and the lung: 4. Obesity and asthma. Thorax 2008; 63:1018.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lang JE, Bunnell HT, Hossain MJ, et al. Being Overweight or Obese and the Development of Asthma. Pediatrics 2018; 142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koebnick C, Fischer H, Daley MF, et al. Interacting effects of obesity, race, ethnicity and sex on the incidence and control of adult-onset asthma. Allergy Asthma Clin Immunol 2016; 12:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175:661.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ali GB, Lowe AJ, Perret JL, et al. Impact of lifetime body mass index trajectories on the incidence and persistence of adult asthma. Eur Respir J 2022; 60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Y, Chen Z, Berhane K, et al. The Dynamic Relationship Between Asthma and Obesity in Schoolchildren. Am J Epidemiol 2020; 189:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moitra S, Carsin AE, Abramson MJ, et al. Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS. Thorax 2023; 78:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Contreras ZA, Chen Z, Roumeliotaki T, et al. Does early onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts. Eur Respir J 2018; 52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hallstrand TS, Fischer ME, Wurfel MM, et al. Genetic pleiotropy between asthma and obesity in a community-based sample of twins. J Allergy Clin Immunol 2005; 116:1235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dhana K, Haines J, Liu G, et al. Association between maternal adherence to healthy lifestyle practices and risk of obesity in offspring: results from two prospective cohort studies of mother-child pairs in the United States. BMJ 2018; 362:k2486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell EA, Stewart AW, Braithwaite I, et al. Factors associated with body mass index in children and adolescents: An international cross-sectional study. PLoS One 2018; 13:e0196221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JS, Alderete TL, Chen Z, et al. Longitudinal associations of in utero and early life near-roadway air pollution with trajectories of childhood body mass index. Environ Health 2018; 17:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buteau S, Doucet M, Tétreault LF, et al. A population-based birth cohort study of the association between childhood-onset asthma and exposure to industrial air pollutant emissions. Environ Int 2018; 121:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics 2012; 129:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brigham EP, Steffen LM, London SJ, et al. Diet Pattern and Respiratory Morbidity in the Atherosclerosis Risk in Communities Study. Ann Am Thorac Soc 2018; 15:675.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Alwan A, Bates JH, Chapman DG, et al. The nonallergic asthma of obesity. A matter of distal lung compliance. Am J Respir Crit Care Med 2014; 189:1494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wood LG, Garg ML, Gibson PG. A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma. J Allergy Clin Immunol 2011; 127:1133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Halnes I, Baines KJ, Berthon BS, et al. Soluble Fibre Meal Challenge Reduces Airway Inflammation and Expression of GPR43 and GPR41 in Asthma. Nutrients 2017; 9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forno E, Weiner DJ, Mullen J, et al. Obesity and Airway Dysanapsis in Children with and without Asthma. Am J Respir Crit Care Med 2017; 195:314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carr TF, Stern DA, Morgan W, et al. Elevated Childhood Insulin-related Asthma Is a Risk Factor for Reduced Lung Function. Am J Respir Crit Care Med 2023; 207:790.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med 2018; 12:755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peters MC, McGrath KW, Hawkins GA, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med 2016; 4:574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon AE, Pratley RE, Forgione PM, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol 2011; 128:508.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Periyalil HA, Wood LG, Wright TA, et al. Obese asthmatics are characterized by altered adipose tissue macrophage activation. Clin Exp Allergy 2018; 48:641.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rastogi D, Fraser S, Oh J, et al. Inflammation, metabolic dysregulation, and pulmonary function among obese urban adolescents with asthma. Am J Respir Crit Care Med 2015; 191:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ather JL, Chung M, Hoyt LR, et al. Weight Loss Decreases Inherent and Allergic Methacholine Hyperresponsiveness in Mouse Models of Diet-Induced Obese Asthma. Am J Respir Cell Mol Biol 2016; 55:176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peters MC, Ringel L, Dyjack N, et al. A Transcriptomic Method to Determine Airway Immune Dysfunction in T2-High and T2-Low Asthma. Am J Respir Crit Care Med 2019; 199:465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nyambuya TM, Dludla PV, Mxinwa V, Nkambule BB. Obesity-related asthma in children is characterized by T-helper 1 rather than T-helper 2 immune response: A meta-analysis. Ann Allergy Asthma Immunol 2020; 125:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Everaere L, Ait Yahia S, Bouté M, et al. Innate lymphoid cells at the interface between obesity and asthma. Immunology 2018; 153:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yon C, Thompson DA, Jude JA, et al. Crosstalk between CD4+ T Cells and Airway Smooth Muscle in Pediatric Obesity-related Asthma. Am J Respir Crit Care Med 2023; 207:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Desai D, Newby C, Symon FA, et al. Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma. Am J Respir Crit Care Med 2013; 188:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holguin F, Comhair SA, Hazen SL, et al. An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. Am J Respir Crit Care Med 2013; 187:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suratt BT, Ubags NDJ, Rastogi D, et al. An Official American Thoracic Society Workshop Report: Obesity and Metabolism. An Emerging Frontier in Lung Health and Disease. Ann Am Thorac Soc 2017; 14:1050.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grasemann H, Holguin F. Oxidative stress and obesity-related asthma. Paediatr Respir Rev 2021; 37:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calco GN, Maung JN, Jacoby DB, et al. Insulin increases sensory nerve density and reflex bronchoconstriction in obese mice. JCI Insight 2022; 7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Babb TG, Ranasinghe KG, Comeau LA, et al. Dyspnea on exertion in obese women: association with an increased oxygen cost of breathing. Am J Respir Crit Care Med 2008; 178:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marines-Price R, Bernhardt V, Bhammar DM, Babb TG. Dyspnea on exertion provokes unpleasantness and negative emotions in women with obesity. Respir Physiol Neurobiol 2019; 260:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernhardt V, Wood HE, Moran RB, Babb TG. Dyspnea on exertion in obese men. Respir Physiol Neurobiol 2013; 185:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holguin F, Bleecker ER, Busse WW, et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol 2011; 127:1486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor B, Mannino D, Brown C, et al. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008; 63:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bal C, Pohl W, Milger K, et al. Characterization of Obesity in Severe Asthma in the German Asthma Net. J Allergy Clin Immunol Pract 2023; 11:3417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mosen DM, Schatz M, Magid DJ, Camargo CA Jr. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol 2008; 122:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quinto KB, Zuraw BL, Poon KY, et al. The association of obesity and asthma severity and control in children. J Allergy Clin Immunol 2011; 128:964.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahmadizar F, Vijverberg SJ, Arets HG, et al. Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis. Eur Respir J 2016; 48:1063.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanagalingam S, Shehab SS, Kaminsky DA, et al. Effect of obesity on sinonasal disease in asthma. J Asthma 2018; 55:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon AE, Shade DM, Cohen RI, et al. Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma 2006; 43:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon AE, Poynter ME. Mechanisms of Asthma in Obesity. Pleiotropic Aspects of Obesity Produce Distinct Asthma Phenotypes. Am J Respir Cell Mol Biol 2016; 54:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forno E. Childhood obesity and asthma: To BMI or not to BMI? J Allergy Clin Immunol 2017; 139:767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           den Dekker HT, Ros KPI, de Jongste JC, et al. Body fat mass distribution and interrupter resistance, fractional exhaled nitric oxide, and asthma at school-age. J Allergy Clin Immunol 2017; 139:810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bates JH. Physiological Mechanisms of Airway Hyperresponsiveness in Obese Asthma. Am J Respir Cell Mol Biol 2016; 54:618.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lugogo N, Green CL, Agada N, et al. Obesity's effect on asthma extends to diagnostic criteria. J Allergy Clin Immunol 2018; 141:1096.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kasteleyn MJ, Bonten TN, de Mutsert R, et al. Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study. Respir Res 2017; 18:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han YY, Forno E, Celedón JC. Adiposity, fractional exhaled nitric oxide, and asthma in U.S. children. Am J Respir Crit Care Med 2014; 190:32.
          </a>
         </li>
         <li class="breakAll">
          2023 Global Initiative for Asthma (GINA) Report: Global Strategy for Asthma Management and Prevention. www.ginasthma.org/2023-gina-main-report (Accessed on May 15, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon AE, Clerisme-Beaty EM, Sugar EA, et al. Effects of obstructive sleep apnea and gastroesophageal reflux disease on asthma control in obesity. J Asthma 2011; 48:707.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teodorescu M, Broytman O, Curran-Everett D, et al. Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II. J Allergy Clin Immunol Pract 2015; 3:566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kasasbeh A, Kasasbeh E, Krishnaswamy G. Potential mechanisms connecting asthma, esophageal reflux, and obesity/sleep apnea complex--a hypothetical review. Sleep Med Rev 2007; 11:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ben Saad H, Ben Hassen I, Ghannouchi I, et al. 6-Min walk-test data in severe obstructive-sleep-apnea-hypopnea-syndrome (OSAHS) under continuous-positive-airway-pressure (CPAP) treatment. Respir Med 2015; 109:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong HS, Williams AJ, Mok Y. The relationship between pulmonary hypertension and obstructive sleep apnea. Curr Opin Pulm Med 2017; 23:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gibeon D, Batuwita K, Osmond M, et al. Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI. Chest 2013; 143:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lang JE, Hossain J, Holbrook JT, et al. Gastro-oesophageal reflux and worse asthma control in obese children: a case of symptom misattribution? Thorax 2016; 71:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perez MK, Piedimonte G. Metabolic asthma: is there a link between obesity, diabetes, and asthma? Immunol Allergy Clin North Am 2014; 34:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Serafino-Agrusa L, Spatafora M, Scichilone N. Asthma and metabolic syndrome: Current knowledge and future perspectives. World J Clin Cases 2015; 3:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peters MC, Schiebler ML, Cardet JC, et al. The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma. Am J Respir Crit Care Med 2022; 206:1096.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapadia SG, Wei C, Bartlett SJ, et al. Obesity and symptoms of depression contribute independently to the poor asthma control of obesity. Respir Med 2014; 108:1100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boudreau M, Bacon SL, Ouellet K, et al. Mediator effect of depressive symptoms on the association between BMI and asthma control in adults. Chest 2014; 146:348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aaron SD, Vandemheen KL, Boulet LP, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008; 179:1121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brazzale DJ, Pretto JJ, Schachter LM. Optimizing respiratory function assessments to elucidate the impact of obesity on respiratory health. Respirology 2015; 20:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Andrilli A, Vanni C, Venuta F, Rendina EA. Critical tracheal stenosis caused by mediastinal lipomatosis: Long-term efficacy of airway stenting. J Thorac Cardiovasc Surg 2015; 149:e109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGarry ME, Castellanos E, Thakur N, et al. Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma. Chest 2015; 147:1591.
          </a>
         </li>
         <li class="breakAll">
          National Asthma Education and Prevention Program, Full Report of the Expert Panel: Guidelines for the Diagnosis and Management of asthma (EPR-3; Source Document),. National Heart, Lung and Blood Institute, Bethesda, MD 2007.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peters-Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006; 27:495.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sutherland ER, Goleva E, Strand M, et al. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008; 178:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007; 101:2240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lang JE, Fitzpatrick AM, Mauger DT, et al. Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids. J Allergy Clin Immunol 2018; 141:1459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363:1715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farzan S, Khan S, Elera C, et al. Effectiveness of montelukast in overweight and obese atopic asthmatics. Ann Allergy Asthma Immunol 2017; 119:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camargo CA Jr, Boulet LP, Sutherland ER, et al. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast. J Asthma 2010; 47:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon AE, Que LG, Kalhan R, et al. Roflumilast May Increase Risk of Exacerbations When Used to Treat Poorly Controlled Asthma in People with Obesity. Ann Am Thorac Soc 2023; 20:206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sposato B, Scalese M, Milanese M, et al. Factors reducing omalizumab response in severe asthma. Eur J Intern Med 2018; 52:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gibson PG, Reddel H, McDonald VM, et al. Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry. Intern Med J 2016; 46:1054.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gu C, Upchurch K, Mamaril-Davis J, et al. Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma. Clin Exp Allergy 2020; 50:1196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geng B, Dixon AE, Ko J, et al. Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma. Ann Allergy Asthma Immunol 2022; 128:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albers FC, Papi A, Taillé C, et al. Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA. Respir Res 2019; 20:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           FitzGerald JM, Bleecker ER, Menzies-Gow A, et al. Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies. Lancet Respir Med 2018; 6:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forte GC, da Silva DTR, Hennemann ML, et al. Diet effects in the asthma treatment: A systematic review. Crit Rev Food Sci Nutr 2018; 58:1878.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kolinsky NC, Weare-Regales N, Lockey RF. A Practical Approach to Assist Asthmatics to Lose Weight. J Allergy Clin Immunol Pract 2021; 9:2245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma V, Ricketts HC, McCombie L, et al. A Total Diet Replacement Weight Management Program for Difficult-to-Treat Asthma Associated With Obesity: A Randomized Controlled Feasibility Trial. Chest 2023; 163:1026.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ma J, Strub P, Xiao L, et al. Behavioral weight loss and physical activity intervention in obese adults with asthma. A randomized trial. Ann Am Thorac Soc 2015; 12:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson O, Gerald LB, Harvey J, et al. An Online Weight Loss Intervention for People With Obesity and Poorly Controlled Asthma. J Allergy Clin Immunol Pract 2022; 10:1577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okoniewski W, Lu KD, Forno E. Weight Loss for Children and Adults with Obesity and Asthma. A Systematic Review of Randomized Controlled Trials. Ann Am Thorac Soc 2019; 16:613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nyenhuis SM, Dixon AE, Ma J. Impact of Lifestyle Interventions Targeting Healthy Diet, Physical Activity, and Weight Loss on Asthma in Adults: What Is the Evidence? J Allergy Clin Immunol Pract 2018; 6:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luna-Pech JA, Torres-Mendoza BM, Luna-Pech JA, et al. Normocaloric diet improves asthma-related quality of life in obese pubertal adolescents. Int Arch Allergy Immunol 2014; 163:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pakhale S, Baron J, Dent R, et al. Effects of weight loss on airway responsiveness in obese adults with asthma: does weight loss lead to reversibility of asthma? Chest 2015; 147:1582.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aaron SD, Fergusson D, Dent R, et al. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004; 125:2046.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boulet LP, Turcotte H, Martin J, Poirier P. Effect of bariatric surgery on airway response and lung function in obese subjects with asthma. Respir Med 2012; 106:651.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baltieri L, Cazzo E, de Souza AL, et al. Influence of weight loss on pulmonary function and levels of adipokines among asthmatic individuals with obesity: One-year follow-up. Respir Med 2018; 145:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guerron AD, Ortega CB, Lee HJ, et al. Asthma medication usage is significantly reduced following bariatric surgery. Surg Endosc 2019; 33:1967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maniscalco M, Zamparelli AS, Vitale DF, et al. Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: A pilot study. Respir Med 2017; 130:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Huisstede A, Rudolphus A, Castro Cabezas M, et al. Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma. Thorax 2015; 70:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hasegawa K, Tsugawa Y, Lopez BL, et al. Body mass index and risk of hospitalization among adults presenting with asthma exacerbation to the emergency department. Ann Am Thorac Soc 2014; 11:1439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hasegawa K, Tsugawa Y, Chang Y, Camargo CA Jr. Risk of an asthma exacerbation after bariatric surgery in adults. J Allergy Clin Immunol 2015; 136:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Green WD, Beck MA. Obesity Impairs the Adaptive Immune Response to Influenza Virus. Ann Am Thorac Soc 2017; 14:S406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Segaloff HE, Evans R, Arshad S, et al. The impact of obesity and timely antiviral administration on severe influenza outcomes among hospitalized adults. J Med Virol 2018; 90:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun Y, Wang Q, Yang G, et al. Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis. Infect Dis (Lond) 2016; 48:813.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torres A, Blasi F, Dartois N, Akova M. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax 2015; 70:984.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 119911 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29627041" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Obesity and asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27019018" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Current Asthma Prevalence by Weight Status Among Adults: United States, 2001-2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18984817" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Obesity and the lung: 4. Obesity and asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30478238" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Being Overweight or Obese and the Development of Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27777591" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Interacting effects of obesity, race, ethnicity and sex on the incidence and control of adult-onset asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17234901" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35210325" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Impact of lifetime body mass index trajectories on the incidence and persistence of adult asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31712801" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The Dynamic Relationship Between Asthma and Obesity in Schoolchildren.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35477559" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30209194" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Does early onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16337451" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Genetic pleiotropy between asthma and obesity in a community-based sample of twins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29973352" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Association between maternal adherence to healthy lifestyle practices and risk of obesity in offspring: results from two prospective cohort studies of mother-child pairs in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29718950" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Factors associated with body mass index in children and adolescents: An international cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30213262" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Longitudinal associations of in utero and early life near-roadway air pollution with trajectories of childhood body mass index.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30172232" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : A population-based birth cohort study of the association between childhood-onset asthma and exposure to industrial air pollutant emissions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22430451" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29446981" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Diet Pattern and Respiratory Morbidity in the Atherosclerosis Risk in Communities Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24821412" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The nonallergic asthma of obesity. A matter of distal lung compliance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21377715" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28075383" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Soluble Fibre Meal Challenge Reduces Airway Inflammation and Expression of GPR43 and GPR41 in Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27552676" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Obesity and Airway Dysanapsis in Children with and without Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36521027" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Elevated Childhood Insulin-related Asthma Is a Risk Factor for Reduced Lung Function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30056777" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The effect of obesity on lung function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27283230" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21782230" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29383778" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Obese asthmatics are characterized by altered adipose tissue macrophage activation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25457349" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Inflammation, metabolic dysregulation, and pulmonary function among obese urban adolescents with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27064658" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Weight Loss Decreases Inherent and Allergic Methacholine Hyperresponsiveness in Mouse Models of Diet-Induced Obese Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30371106" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : A Transcriptomic Method to Determine Airway Immune Dysfunction in T2-High and T2-Low Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32561508" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Obesity-related asthma in children is characterized by T-helper 1 rather than T-helper 2 immune response: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28880992" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Innate lymphoid cells at the interface between obesity and asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36194662" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Crosstalk between CD4+ T Cells and Airway Smooth Muscle in Pediatric Obesity-related Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23590263" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23204252" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28570148" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : An Official American Thoracic Society Workshop Report: Obesity and Metabolism. An Emerging Frontier in Lung Health and Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32660723" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Oxidative stress and obesity-related asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36107629" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Insulin increases sensory nerve density and reflex bronchoconstriction in obese mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18420968" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Dyspnea on exertion in obese women: association with an increased oxygen cost of breathing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30471435" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Dyspnea on exertion provokes unpleasantness and negative emotions in women with obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23085240" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Dyspnea on exertion in obese men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21624618" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Obesity and asthma: an association modified by age of asthma onset.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18156567" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Body mass index and asthma severity in the National Asthma Survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37406803" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Characterization of Obesity in Severe Asthma in the German Asthma Net.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18774387" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : The relationship between obesity and asthma severity and control in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21820711" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : The association of obesity and asthma severity and control in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27587561" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28737966" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Effect of obesity on sinonasal disease in asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16939998" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Effect of obesity on clinical presentation and response to treatment in asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26886277" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Mechanisms of Asthma in Obesity. Pleiotropic Aspects of Obesity Produce Distinct Asthma Phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27658759" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Childhood obesity and asthma: To BMI or not to BMI?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27592177" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Body fat mass distribution and interrupter resistance, fractional exhaled nitric oxide, and asthma at school-age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26909510" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Physiological Mechanisms of Airway Hyperresponsiveness in Obese Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28624608" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Obesity's effect on asthma extends to diagnostic criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29212496" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24922361" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Adiposity, fractional exhaled nitric oxide, and asthma in U.S. children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24922361" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Adiposity, fractional exhaled nitric oxide, and asthma in U.S. children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21819338" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Effects of obstructive sleep apnea and gastroesophageal reflux disease on asthma control in obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26004304" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17198758" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Potential mechanisms connecting asthma, esophageal reflux, and obesity/sleep apnea complex--a hypothetical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25820157" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : 6-Min walk-test data in severe obstructive-sleep-apnea-hypopnea-syndrome (OSAHS) under continuous-positive-airway-pressure (CPAP) treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28786883" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : The relationship between pulmonary hypertension and obstructive sleep apnea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23064546" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26834184" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Gastro-oesophageal reflux and worse asthma control in obese children: a case of symptom misattribution?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25282290" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Metabolic asthma: is there a link between obesity, diabetes, and asthma?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25789301" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Asthma and metabolic syndrome: Current knowledge and future perspectives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35687105" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24947900" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Obesity and symptoms of depression contribute independently to the poor asthma control of obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24676351" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Mediator effect of depressive symptoms on the association between BMI and asthma control in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19015563" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Overdiagnosis of asthma in obese and nonobese adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26033636" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Optimizing respiratory function assessments to elucidate the impact of obesity on respiratory health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25686656" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Critical tracheal stenosis caused by mediastinal lipomatosis: Long-term efficacy of airway stenting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25742612" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25742612" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16507848" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Influence of body mass index on the response to asthma controller agents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18635892" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Body mass and glucocorticoid response in asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17686624" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29273557" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20979471" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Tiotropium bromide step-up therapy for adults with uncontrolled asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28668546" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Effectiveness of montelukast in overweight and obese atopic asthmatics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20100025" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36170654" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Roflumilast May Increase Risk of Exacerbations When Used to Treat Poorly Controlled Asthma in People with Obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29395935" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Factors reducing omalizumab response in severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27350385" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32585057" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35101644" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31362741" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28919200" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28362110" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Diet effects in the asthma treatment: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33516924" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : A Practical Approach to Assist Asthmatics to Lose Weight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36649753" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : A Total Diet Replacement Weight Management Program for Difficult-to-Treat Asthma Associated With Obesity: A Randomized Controlled Feasibility Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25496399" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Behavioral weight loss and physical activity intervention in obese adults with asthma. A randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35304842" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : An Online Weight Loss Intervention for People With Obesity and Poorly Controlled Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30605347" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Weight Loss for Children and Adults with Obesity and Asthma. A Systematic Review of Randomized Controlled Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29221919" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Impact of Lifestyle Interventions Targeting Healthy Diet, Physical Activity, and Weight Loss on Asthma in Adults: What Is the Evidence?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24713632" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Normocaloric diet improves asthma-related quality of life in obese pubertal adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25763936" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Effects of weight loss on airway responsiveness in obese adults with asthma: does weight loss lead to reversibility of asthma?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15189920" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Effect of weight reduction on respiratory function and airway reactivity in obese women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22326605" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Effect of bariatric surgery on airway response and lung function in obese subjects with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30509716" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Influence of weight loss on pulmonary function and levels of adipokines among asthmatic individuals with obesity: One-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30334159" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Asthma medication usage is significantly reduced following bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29206636" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: A pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25934136" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25314160" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Body mass index and risk of hospitalization among adults presenting with asthma exacerbation to the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25670012" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Risk of an asthma exacerbation after bariatric surgery in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29161078" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Obesity Impairs the Adaptive Immune Response to Influenza Virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28892181" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : The impact of obesity and timely antiviral administration on severe influenza outcomes among hospitalized adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27385315" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26219979" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
